Agricultural Animal Vaccine Market Size, Share and Trends Analysis Report, By Type (Live Attenuated Vaccines, Inactivated Vaccines, Others), By Application (Cow, Sheep, Swine, Chicken, and Others), Forecast (2022-2028)

The global agriculture animal vaccine market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The increase in the prevalence of the animal disease has created a demand for the development of live attenuated vaccines for its treatment which in turn drives the global agriculture animal vaccine market growth. Major healthcare companies are focusing on the development of vaccines for inducing humoral treatment. The market growth is driven by the strong focus of the healthcare companies and research organizations on the R&D of vaccines for the agricultural animal creating a strong pipeline for effective therapy.

In addition, a few organizations are investing in the development of antibodies against COVID-19. For instance, in March 2021, Zoetis makes a vaccine for mink and its associated animals and according to the agriculture animal and Life Journal of the Russian Federal Veterinary and Phytosanitary, it is the Carnival-Cov vaccine aimed at preventing the spread of SARS-CoV-2 in animals such as dogs, cats, and mink was introduced in Russia and the government support for the increase in cases of animal infections is ready to benefit the agriculture animal vaccine market.

Growing demand for meat has led to greater productivity, as livestock farms live with animals in very densely populated areas that prove rapid pathogen transmission and cause infectious diseases. According to the World Organization for Animal Health (OIE), from 2016 to 2020, significant increases in the number of African swine fever (ASF) outbreaks have been reported in Africa, Europe, and Asia. The virus was present in 60 countries and killed an estimated 8,202,702 pigs. In the first five months of 2021, Polish authorities reported a 520% ​​increase in ASF outbreaks in domestic herds of pigs. The ongoing threat posed by pandemic and viral infections has led to the development of an agricultural animal vaccines market that provides effective clinical efficacy.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape-AbbVie Inc., Eisai Co. Ltd.,Pfizer Inc,., Merck & Co., Inc., Zoetis Inc., and Sanofi S.A.,among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Agriculture animal vaccine Market Report by Segment

By Type

• Live Attenuated Vaccines
• Inactivated Vaccines
• Others

By Application

• Cow
• Sheep
• Swine
• Chicken
• Others

Global Agriculture Animal Vaccine Market Report by Region

North America

• US
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa